AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JAYWING PLC

Regulatory Filings Aug 30, 2019

7728_rns_2019-08-30_2bf97c28-7712-41e1-aac1-eced64a5e9e5.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6310K

Jaywing PLC

30 August 2019

Information contained within this announcement was deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

30 August 2019

Jaywing plc

("Jaywing" or the "Company")

Further re. trading update and results

On 10 July 2019 the Company issued a trading statement advising that trading in the first quarter of the current financial year had been very weak and that the Company expected to publish its preliminary results for the year to 31 March 2019 ("2019 Preliminary Results") before the end of August 2019.    

Trading has improved since the end of June but conditions remain challenging with client activity adversely impacted by the uncertain economic and political outlook.  As a result, the Directors have been in negotiation with the Company's bank and its two major shareholders with a view to strengthening the Company's balance sheet.  These negotiations remain ongoing and constructive.

The Company announces that it now expects to publish its 2019 Preliminary Results by the end of September 2019.

Jaywing plc (www.jaywingplc.com)

Michael Sprot (Company Secretary)

Tel: 0114 281 1200

Cenkos Securities plc

Nicholas Wells/Callum Davidson (Nominated Adviser)

Tel: 0207 397 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

FURPLMLTMBTTBIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.